Parties d'ouvrages collectifs (4)

  1. 1. Moles Lopez, X., Debeir, O., Salmon, I., & Decaestecker, C. (2014). Whole slide imaging and analysis for biomarker evaluation in digital pathology. In In: A. Méndez-Vilas (Ed.), Microscopy: advances in scientific research and education (pp. 776-787). Formatex Research Center.
  2. 2. Salmon, I., Michaud, K., Piercecchi-Marti, M.-D., Delbecque, K., Mangin, P., Rolin, S., Beauthier, F., & Beauthier, J.-P. (2007). Anatomie pathologique macroscopique et microscopique: quelques aspects médico-légaux utiles. In J.-P. Beauthier (Ed.), Traité de médecine légale (pp. 565-600). De Boeck.
  3. 3. Danguy, A., Salmon, I., & Kiss, R. (2002). Modern glycohistochemistry: A major contribution to morphological investigations. In H.-J. Gabius & S. Gabius (Eds.), Glycosciences: status and perspectives (pp. 547-562). Wiley.
  4. 4. Jouvet, A., Salmon, I., Tommasi, M., Saint-Pierre, G., & Rousselet, M. (1996). Neuropathology. In G. Fisher & J. Brotchi (Eds.), Intramedullary spinal cord tumors (pp. 21-24). Thieme.
  5.   Articles dans des revues avec comité de lecture (363)

  6. 1. Belcour, M., Dontaine, P., Monier, A., Lebrun, L., Salmon, I., De Witte, O., Goldman, S., De Tiege, X., & Aeby, A. (2022). Case Report: Interest of Positron Emission Tomography in Pediatric Small Vessel Primary Angiitis of the Central Nervous System. Frontiers in Pediatrics, 10, 794294. doi:10.3389/fped.2022.794294
  7. 2. Racu, M.-L., Lebrun, L., Schiavo, A. A., Van Campenhout, C., De Clercq, S., Absil, L., Minguijon Perez, E., Maris, C., Decaestecker, C., Salmon, I., & D'Haene, N. (2022). The Role of SMAD4 Inactivation in Epithelial-Mesenchymal Plasticity of Pancreatic Ductal Adenocarcinoma: The Missing Link? Cancers (Basel), 14(4). doi:10.3390/cancers14040973
  8. 3. Rusu, S., Verocq, C., Trepant, A.-L., Maris, C., De Nève, N., Blanchard, O., Van Campenhout, C., De Clercq, S., Rorive, S., Cotoi, O. S., Decaestecker, C., Salmon, I., & D'Haene, N. (2021). Immunohistochemistry as an accurate tool for the assessment of BRAF V600E and TP53 mutations in primary and metastatic melanoma. Molecular and clinical oncology, 15(6), 270. doi:10.3892/mco.2021.2432
  9. 4. Martens, C., Lebrun, L., Decaestecker, C., Vandamme, T., Van Eycke, Y.-R., Rovai, A., Metens, T., Debeir, O., Goldman, S., Salmon, I., & Van Simaeys, G. (2021). Initial Condition Assessment for Reaction-Diffusion Glioma Growth Models: A Translational MRI-Histology (In)Validation Study. Tomography, 7(4), 650-674. doi:10.3390/tomography7040055
  10. 5. Mauri, F., Schepkens, C., Lapouge, G., Drogat, B., Song, Y., Pastushenko, I., Rorive, S., Blondeau, J., Golstein, S., Bareche, Y., Miglianico, M., Nkusi, E., Rozzi, M., Moers, V., Brisebarre, A., Raphael, M., Dubois, C., Durdu, B., Ribeiro, F., Sotiriou, C., Salmon, I., Vakili, J., Blanpain, C., Mauri, F., Schepkens, C., Lapouge, G., Drogat, B., Song, Y., Pastushenko, I., Rorive, S., Blondeau, J., Golstein, S., Bareche, Y., Miglianico, M., Nkusi, E., Rozzi, M., Moers, V., Brisebarre, A., Raphael, M., Dubois, C., Durdu, B., Ribeiro, F., Sotiriou, C., Salmon, I., Vakili, J., & Blanpain, C. (2021). NR2F2 controls malignant squamous cell carcinoma state by promoting stemness and invasion and repressing differentiation. Nature Cancer, 2(11), 1152-1169. doi:10.1038/s43018-021-00287-5
  11. 6. Lebrun, L., Bizet, M., Melendez Asensio, B., Alexiou, B., Absil, L., Van Campenhout, C., D'Haene, N., Rorive, S., Fuks, F., Decaestecker, C., & Salmon, I. (2021). Analyses of DNA Methylation Profiling in the Diagnosis of Intramedullary Astrocytomas. Journal of neuropathology and experimental neurology, 80(7), 663-673. doi:10.1093/jnen/nlab052
  12. 7. Rusu, S., Lavis, P., Domingues Salgado, V., Van Craynest, M. P., Creteur, J., Salmon, I., Brasseur, A., & Remmelink, M. (2021). Comparison of antemortem clinical diagnosis and post-mortem findings in intensive care unit patients. Virchows Archiv, 479(2), 385-392. doi:10.1007/s00428-020-03016-y
  13. 8. Duerinck, J., Schwarze, J. K., Awada, G., Tijtgat, J., Vaeyens, F., Bertels, C., Geens, W., Klein, S., Seynaeve, L., Cras, L., D'Haene, N., Michotte, A., Caljon, B., Salmon, I., Bruneau, M., Kockx, M., Van Dooren, S., Vanbinst, A., Everaert, H., Forsyth, R., & Neyns, B. (2021). Intracerebral administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in patients with recurrent glioblastoma: A phase i clinical trial. Journal for ImmunoTherapy of Cancer, 9(6), e002296. doi:10.1136/jitc-2020-002296

  14. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37
    38 39 40 41 42 43 44 Suivant >>